These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29331227)

  • 1. The impact of technology on the changing practice of lung SBRT.
    Aznar MC; Warren S; Hoogeman M; Josipovic M
    Phys Med; 2018 Mar; 47():129-138. PubMed ID: 29331227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging technologies in stereotactic body radiotherapy.
    Ma L; Wang L; Tseng CL; Sahgal A
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
    Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
    J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontiers in planning optimization for lung SBRT.
    Giglioli FR; Clemente S; Esposito M; Fiandra C; Marino C; Russo S; Strigari L; Villaggi E; Stasi M; Mancosu P
    Phys Med; 2017 Dec; 44():163-170. PubMed ID: 28566240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for early stage lung cancer-historical developments and future strategies.
    Chua KLM; Sin I; Fong KW; Chua MLK; Onishi H
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S20. PubMed ID: 28917258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrafraction 4D-cone beam CT acquired during volumetric arc radiotherapy delivery: kV parameter optimization and 4D motion accuracy for lung stereotactic body radiotherapy (SBRT) patients.
    Liang J; Lack D; Zhou J; Liu Q; Grills I; Yan D
    J Appl Clin Med Phys; 2019 Dec; 20(12):10-24. PubMed ID: 31675150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-guided lung SBRT: Present and future developments.
    Menten MJ; Wetscherek A; Fast MF
    Phys Med; 2017 Dec; 44():139-149. PubMed ID: 28242140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.
    Sahgal A; Roberge D; Schellenberg D; Purdie TG; Swaminath A; Pantarotto J; Filion E; Gabos Z; Butler J; Letourneau D; Masucci GL; Mulroy L; Bezjak A; Dawson LA; Parliament M;
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):629-39. PubMed ID: 22633542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
    Han C; Sampath S; Schultheisss TE; Wong JYC
    Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
    Rieber J; Abbassi-Senger N; Adebahr S; Andratschke N; Blanck O; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Lohr F; Petersen C; Schrade E; Streblow J; Uhlmann L; Wittig A; Sterzing F; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):511-520. PubMed ID: 27843031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distributive quality assurance and delivery of stereotactic ablative radiotherapy treatments amongst beam matched linear accelerators: A feasibility study.
    Rijken J; Schachenmayr H; Crowe S; Kairn T; Trapp J
    J Appl Clin Med Phys; 2019 Apr; 20(4):99-105. PubMed ID: 30883010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.
    Prendergast BM; Dobelbower MC; Bonner JA; Popple RA; Baden CJ; Minnich DJ; Cerfolio RJ; Spencer SA; Fiveash JB
    Radiat Oncol; 2013 Nov; 8():273. PubMed ID: 24256563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
    Shang H; Pu Y; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours.
    Hoffmann L; Persson GF; Nygård L; Nielsen TB; Borrisova S; Gaard-Petersen F; Josipovic M; Khalil AA; Kjeldsen R; Knap MM; Kristiansen C; Møller DS; Ottosson W; Sand H; Thing R; Pøhl M; Schytte T
    Radiother Oncol; 2022 Jun; 171():53-61. PubMed ID: 35421513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy.
    Matuszak MM; Hadley SW; Feng M; Hayman JA; Brock KK; Burger P; Owen D; Suresh K; Schipper M; Lawrence TS; Moran JM
    Pract Radiat Oncol; 2016; 6(2):e39-46. PubMed ID: 26746815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.